カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界のES細胞無血清培地市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Embryonic Stem Cell Serum-free Medium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7027）・商品コード：GIR23SM7027
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のES細胞無血清培地の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のES細胞無血清培地市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ES細胞無血清培地の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ES細胞無血清培地市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・基本培地、フィード培地

用途別セグメント
・病院、医学部研究室、医学研究所

主要な市場プレーヤー
・Merck、Thermo Fisher Scientific、Weike Bio Technology、Cyagen、Ajinomoto、Celprogen、Cytiva、InVitria、Kohjin Bio、Miltenyi Biotec、PELOBiotech、R&D Systems、Sartorius、Sigma-Aldrich、Stemcell、Takara Bio

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ES細胞無血清培地製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なES細胞無血清培地メーカーの企業概要、2019年～2022年までのES細胞無血清培地の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なES細胞無血清培地メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ES細胞無血清培地の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのES細胞無血清培地のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのES細胞無血清培地市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびES細胞無血清培地の産業チェーンを掲載しています。
・第14、15章では、ES細胞無血清培地の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ES細胞無血清培地の概要
– タイプ別分析（2018年vs2022年vs2029年）：基本培地、フィード培地
– 用途別分析（2018年vs2022年vs2029年）：病院、医学部研究室、医学研究所
– 世界のES細胞無血清培地市場規模・予測
– 世界のES細胞無血清培地生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Thermo Fisher Scientific、Weike Bio Technology、Cyagen、Ajinomoto、Celprogen、Cytiva、InVitria、Kohjin Bio、Miltenyi Biotec、PELOBiotech、R&D Systems、Sartorius、Sigma-Aldrich、Stemcell、Takara Bio
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：基本培地、フィード培地
・用途別分析2018年-2029年：病院、医学部研究室、医学研究所
・ES細胞無血清培地の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ES細胞無血清培地のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ES細胞無血清培地のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ES細胞無血清培地の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ES細胞無血清培地の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Embryonic Stem Cell Serum-free Medium
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Basal Medium
1.3.3 Feed Medium
1.4 Market Analysis by Application
1.4.1 Overview: Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Medical School Laboratory
1.4.4 Medical Research Institute
1.5 Global Embryonic Stem Cell Serum-free Medium Market Size & Forecast
1.5.1 Global Embryonic Stem Cell Serum-free Medium Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Embryonic Stem Cell Serum-free Medium Sales Quantity (2018-2029)
1.5.3 Global Embryonic Stem Cell Serum-free Medium Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Embryonic Stem Cell Serum-free Medium Product and Services
2.1.4 Merck Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Product and Services
2.2.4 Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments/Updates
2.3 Weike Bio Technology
2.3.1 Weike Bio Technology Details
2.3.2 Weike Bio Technology Major Business
2.3.3 Weike Bio Technology Embryonic Stem Cell Serum-free Medium Product and Services
2.3.4 Weike Bio Technology Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Weike Bio Technology Recent Developments/Updates
2.4 Cyagen
2.4.1 Cyagen Details
2.4.2 Cyagen Major Business
2.4.3 Cyagen Embryonic Stem Cell Serum-free Medium Product and Services
2.4.4 Cyagen Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cyagen Recent Developments/Updates
2.5 Ajinomoto
2.5.1 Ajinomoto Details
2.5.2 Ajinomoto Major Business
2.5.3 Ajinomoto Embryonic Stem Cell Serum-free Medium Product and Services
2.5.4 Ajinomoto Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ajinomoto Recent Developments/Updates
2.6 Celprogen
2.6.1 Celprogen Details
2.6.2 Celprogen Major Business
2.6.3 Celprogen Embryonic Stem Cell Serum-free Medium Product and Services
2.6.4 Celprogen Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celprogen Recent Developments/Updates
2.7 Cytiva
2.7.1 Cytiva Details
2.7.2 Cytiva Major Business
2.7.3 Cytiva Embryonic Stem Cell Serum-free Medium Product and Services
2.7.4 Cytiva Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cytiva Recent Developments/Updates
2.8 InVitria
2.8.1 InVitria Details
2.8.2 InVitria Major Business
2.8.3 InVitria Embryonic Stem Cell Serum-free Medium Product and Services
2.8.4 InVitria Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 InVitria Recent Developments/Updates
2.9 Kohjin Bio
2.9.1 Kohjin Bio Details
2.9.2 Kohjin Bio Major Business
2.9.3 Kohjin Bio Embryonic Stem Cell Serum-free Medium Product and Services
2.9.4 Kohjin Bio Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kohjin Bio Recent Developments/Updates
2.10 Miltenyi Biotec
2.10.1 Miltenyi Biotec Details
2.10.2 Miltenyi Biotec Major Business
2.10.3 Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Product and Services
2.10.4 Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Miltenyi Biotec Recent Developments/Updates
2.11 PELOBiotech
2.11.1 PELOBiotech Details
2.11.2 PELOBiotech Major Business
2.11.3 PELOBiotech Embryonic Stem Cell Serum-free Medium Product and Services
2.11.4 PELOBiotech Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PELOBiotech Recent Developments/Updates
2.12 R&D Systems
2.12.1 R&D Systems Details
2.12.2 R&D Systems Major Business
2.12.3 R&D Systems Embryonic Stem Cell Serum-free Medium Product and Services
2.12.4 R&D Systems Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 R&D Systems Recent Developments/Updates
2.13 Sartorius
2.13.1 Sartorius Details
2.13.2 Sartorius Major Business
2.13.3 Sartorius Embryonic Stem Cell Serum-free Medium Product and Services
2.13.4 Sartorius Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sartorius Recent Developments/Updates
2.14 Sigma-Aldrich
2.14.1 Sigma-Aldrich Details
2.14.2 Sigma-Aldrich Major Business
2.14.3 Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Product and Services
2.14.4 Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sigma-Aldrich Recent Developments/Updates
2.15 Stemcell
2.15.1 Stemcell Details
2.15.2 Stemcell Major Business
2.15.3 Stemcell Embryonic Stem Cell Serum-free Medium Product and Services
2.15.4 Stemcell Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Stemcell Recent Developments/Updates
2.16 Takara Bio
2.16.1 Takara Bio Details
2.16.2 Takara Bio Major Business
2.16.3 Takara Bio Embryonic Stem Cell Serum-free Medium Product and Services
2.16.4 Takara Bio Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Takara Bio Recent Developments/Updates
3 Competitive Environment: Embryonic Stem Cell Serum-free Medium by Manufacturer
3.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Manufacturer (2018-2023)
3.2 Global Embryonic Stem Cell Serum-free Medium Revenue by Manufacturer (2018-2023)
3.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Embryonic Stem Cell Serum-free Medium by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Embryonic Stem Cell Serum-free Medium Manufacturer Market Share in 2022
3.4.2 Top 6 Embryonic Stem Cell Serum-free Medium Manufacturer Market Share in 2022
3.5 Embryonic Stem Cell Serum-free Medium Market: Overall Company Footprint Analysis
3.5.1 Embryonic Stem Cell Serum-free Medium Market: Region Footprint
3.5.2 Embryonic Stem Cell Serum-free Medium Market: Company Product Type Footprint
3.5.3 Embryonic Stem Cell Serum-free Medium Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Embryonic Stem Cell Serum-free Medium Market Size by Region
4.1.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2029)
4.1.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2029)
4.1.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Region (2018-2029)
4.2 North America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.3 Europe Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.4 Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.5 South America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.6 Middle East and Africa Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
5.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type (2018-2029)
5.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
6.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application (2018-2029)
6.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Application (2018-2029)
7 North America
7.1 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
7.2 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
7.3 North America Embryonic Stem Cell Serum-free Medium Market Size by Country
7.3.1 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
7.3.2 North America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
8.2 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
8.3 Europe Embryonic Stem Cell Serum-free Medium Market Size by Country
8.3.1 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
8.3.2 Europe Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Embryonic Stem Cell Serum-free Medium Market Size by Region
9.3.1 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
10.2 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
10.3 South America Embryonic Stem Cell Serum-free Medium Market Size by Country
10.3.1 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
10.3.2 South America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Embryonic Stem Cell Serum-free Medium Market Size by Country
11.3.1 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Embryonic Stem Cell Serum-free Medium Market Drivers
12.2 Embryonic Stem Cell Serum-free Medium Market Restraints
12.3 Embryonic Stem Cell Serum-free Medium Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Embryonic Stem Cell Serum-free Medium and Key Manufacturers
13.2 Manufacturing Costs Percentage of Embryonic Stem Cell Serum-free Medium
13.3 Embryonic Stem Cell Serum-free Medium Production Process
13.4 Embryonic Stem Cell Serum-free Medium Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Embryonic Stem Cell Serum-free Medium Typical Distributors
14.3 Embryonic Stem Cell Serum-free Medium Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Embryonic Stem Cell Serum-free Medium Product and Services
Table 6. Merck Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Scientific Major Business
Table 10. Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Product and Services
Table 11. Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Thermo Fisher Scientific Recent Developments/Updates
Table 13. Weike Bio Technology Basic Information, Manufacturing Base and Competitors
Table 14. Weike Bio Technology Major Business
Table 15. Weike Bio Technology Embryonic Stem Cell Serum-free Medium Product and Services
Table 16. Weike Bio Technology Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Weike Bio Technology Recent Developments/Updates
Table 18. Cyagen Basic Information, Manufacturing Base and Competitors
Table 19. Cyagen Major Business
Table 20. Cyagen Embryonic Stem Cell Serum-free Medium Product and Services
Table 21. Cyagen Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cyagen Recent Developments/Updates
Table 23. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 24. Ajinomoto Major Business
Table 25. Ajinomoto Embryonic Stem Cell Serum-free Medium Product and Services
Table 26. Ajinomoto Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ajinomoto Recent Developments/Updates
Table 28. Celprogen Basic Information, Manufacturing Base and Competitors
Table 29. Celprogen Major Business
Table 30. Celprogen Embryonic Stem Cell Serum-free Medium Product and Services
Table 31. Celprogen Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Celprogen Recent Developments/Updates
Table 33. Cytiva Basic Information, Manufacturing Base and Competitors
Table 34. Cytiva Major Business
Table 35. Cytiva Embryonic Stem Cell Serum-free Medium Product and Services
Table 36. Cytiva Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cytiva Recent Developments/Updates
Table 38. InVitria Basic Information, Manufacturing Base and Competitors
Table 39. InVitria Major Business
Table 40. InVitria Embryonic Stem Cell Serum-free Medium Product and Services
Table 41. InVitria Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. InVitria Recent Developments/Updates
Table 43. Kohjin Bio Basic Information, Manufacturing Base and Competitors
Table 44. Kohjin Bio Major Business
Table 45. Kohjin Bio Embryonic Stem Cell Serum-free Medium Product and Services
Table 46. Kohjin Bio Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kohjin Bio Recent Developments/Updates
Table 48. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 49. Miltenyi Biotec Major Business
Table 50. Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Product and Services
Table 51. Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Miltenyi Biotec Recent Developments/Updates
Table 53. PELOBiotech Basic Information, Manufacturing Base and Competitors
Table 54. PELOBiotech Major Business
Table 55. PELOBiotech Embryonic Stem Cell Serum-free Medium Product and Services
Table 56. PELOBiotech Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. PELOBiotech Recent Developments/Updates
Table 58. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 59. R&D Systems Major Business
Table 60. R&D Systems Embryonic Stem Cell Serum-free Medium Product and Services
Table 61. R&D Systems Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. R&D Systems Recent Developments/Updates
Table 63. Sartorius Basic Information, Manufacturing Base and Competitors
Table 64. Sartorius Major Business
Table 65. Sartorius Embryonic Stem Cell Serum-free Medium Product and Services
Table 66. Sartorius Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sartorius Recent Developments/Updates
Table 68. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 69. Sigma-Aldrich Major Business
Table 70. Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Product and Services
Table 71. Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sigma-Aldrich Recent Developments/Updates
Table 73. Stemcell Basic Information, Manufacturing Base and Competitors
Table 74. Stemcell Major Business
Table 75. Stemcell Embryonic Stem Cell Serum-free Medium Product and Services
Table 76. Stemcell Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Stemcell Recent Developments/Updates
Table 78. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 79. Takara Bio Major Business
Table 80. Takara Bio Embryonic Stem Cell Serum-free Medium Product and Services
Table 81. Takara Bio Embryonic Stem Cell Serum-free Medium Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Takara Bio Recent Developments/Updates
Table 83. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Embryonic Stem Cell Serum-free Medium Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Embryonic Stem Cell Serum-free Medium Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Embryonic Stem Cell Serum-free Medium, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Embryonic Stem Cell Serum-free Medium Production Site of Key Manufacturer
Table 88. Embryonic Stem Cell Serum-free Medium Market: Company Product Type Footprint
Table 89. Embryonic Stem Cell Serum-free Medium Market: Company Product Application Footprint
Table 90. Embryonic Stem Cell Serum-free Medium New Market Entrants and Barriers to Market Entry
Table 91. Embryonic Stem Cell Serum-free Medium Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Embryonic Stem Cell Serum-free Medium Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Embryonic Stem Cell Serum-free Medium Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Embryonic Stem Cell Serum-free Medium Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Embryonic Stem Cell Serum-free Medium Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Embryonic Stem Cell Serum-free Medium Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Embryonic Stem Cell Serum-free Medium Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Embryonic Stem Cell Serum-free Medium Raw Material
Table 151. Key Manufacturers of Embryonic Stem Cell Serum-free Medium Raw Materials
Table 152. Embryonic Stem Cell Serum-free Medium Typical Distributors
Table 153. Embryonic Stem Cell Serum-free Medium Typical Customers
List of Figures
Figure 1. Embryonic Stem Cell Serum-free Medium Picture
Figure 2. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Type in 2022
Figure 4. Basal Medium Examples
Figure 5. Feed Medium Examples
Figure 6. Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Medical School Laboratory Examples
Figure 10. Medical Research Institute Examples
Figure 11. Global Embryonic Stem Cell Serum-free Medium Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Embryonic Stem Cell Serum-free Medium Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Embryonic Stem Cell Serum-free Medium Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Embryonic Stem Cell Serum-free Medium Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Embryonic Stem Cell Serum-free Medium by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Embryonic Stem Cell Serum-free Medium Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Embryonic Stem Cell Serum-free Medium Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Embryonic Stem Cell Serum-free Medium Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Embryonic Stem Cell Serum-free Medium Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Region (2018-2029)
Figure 53. China Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Embryonic Stem Cell Serum-free Medium Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Embryonic Stem Cell Serum-free Medium Market Drivers
Figure 74. Embryonic Stem Cell Serum-free Medium Market Restraints
Figure 75. Embryonic Stem Cell Serum-free Medium Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Embryonic Stem Cell Serum-free Medium in 2022
Figure 78. Manufacturing Process Analysis of Embryonic Stem Cell Serum-free Medium
Figure 79. Embryonic Stem Cell Serum-free Medium Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


★調査レポート[世界のES細胞無血清培地市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7027)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のES細胞無血清培地市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のES細胞培養液市場2023年：企業・地域・タイプ・用途別分析
  • 世界の無血清細胞凍結培地市場2023年：企業・地域・タイプ・用途別分析
  • 世界の免疫細胞無血清培地市場2023年：企業・地域・タイプ・用途別分析
  • 世界の間葉系幹細胞培養液市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト線維芽細胞培養液市場2023年：企業・地域・タイプ・用途別分析
  • 世界の人工血清市場2023年：企業・地域・タイプ・用途別分析
  • 世界の組換えヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の内皮細胞基本培地市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆